Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis
…, RH Weenig, JL Hand, MR Pittelkow, BA Pockaj… - Mayo Clinic …, 2007 - Elsevier
Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
[HTML][HTML] Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials …
J Franko, Q Shi, CD Goldman, BA Pockaj… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Purpose Symptoms and complications of metastatic colorectal cancer (mCRC) differ by
metastatic sites. There is a paucity of prospective survival data for patients with peritoneal …
metastatic sites. There is a paucity of prospective survival data for patients with peritoneal …
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
…, JT Quesenberry, TA Webb, GH Farr, BA Pockaj… - Jama, 2012 - jamanetwork.com
Context Leucovorin, fluorouracil, and oxaliplatin (FOLFOX) is the standard adjuvant therapy
for resected stage III colon cancer. Adding cetuximab to FOLFOX benefits patients with …
for resected stage III colon cancer. Adding cetuximab to FOLFOX benefits patients with …
Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience
CCH Stucky, KN Johnson, RJ Gray, BA Pockaj… - Annals of surgical …, 2012 - Springer
Background Malignant peripheral nerve sheath tumors (MPNST) are a rare form of soft tissue
sarcoma with few studies reporting on patient outcomes and prognostic variables. Methods …
sarcoma with few studies reporting on patient outcomes and prognostic variables. Methods …
Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis
EC McLemore, BA Pockaj, C Reynolds, RJ Gray… - Annals of surgical …, 2005 - Springer
Background Breast cancer metastatic to the gastrointestinal tract or peritoneum is rare. We
reviewed the natural history of ductal and lobular carcinoma in women with breast cancer …
reviewed the natural history of ductal and lobular carcinoma in women with breast cancer …
DIEP and pedicled TRAM flaps: a comparison of outcomes
PB Garvey, EW Buchel, BA Pockaj… - Plastic and …, 2006 - journals.lww.com
Background: Studies comparing similar and sizable numbers of deep inferior epigastric
perforator (DIEP) and pedicled transverse rectus abdominis musculocutaneous (TRAM) flap …
perforator (DIEP) and pedicled transverse rectus abdominis musculocutaneous (TRAM) flap …
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference
…, CD Lehman, JR Harris, BA Pockaj… - Journal of Clinical …, 2008 - ascopubs.org
Purpose To review the state of the science with respect to diagnostic imaging and locoregional
therapy for patients with breast cancer receiving preoperative chemotherapy. Methods …
therapy for patients with breast cancer receiving preoperative chemotherapy. Methods …
[HTML][HTML] Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108)
…, M Basik, M Golshan, TB Julian, BA Pockaj… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE Distant metastases are present in 6% or more of patients with newly diagnosed
breast cancer. In this context, locoregional therapy for the intact primary tumor has been …
breast cancer. In this context, locoregional therapy for the intact primary tumor has been …
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
…, JN Weitzel, TP Slavin, C Caldas, BA Pockaj… - Science translational …, 2019 - science.org
Longitudinal analysis of circulating tumor DNA (ctDNA) has shown promise for monitoring
treatment response. However, most current methods lack adequate sensitivity for residual …
treatment response. However, most current methods lack adequate sensitivity for residual …
Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer
BA Pockaj, GD Basu, LB Pathangey, RJ Gray… - Annals of Surgical …, 2004 - Springer
Background: In several neoplastic diseases, including breast cancer, immunosuppression
correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune …
correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune …
